Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01174602 · ClinicalTrials.gov registry record · NA

Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa

A NA study, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT01174602: Completed NA study, sponsored by New York State Psychiatric Institute.

NCT01174602 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01174602, a NA study, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Exposure and response prevention (AN-EXRP) will help individuals with anorexia nervosa improve their eating behavior.

Primary Outcome

Eating behavior will be measured as both intake patterns in food records and in a laboratory based meal.

Interventions

  • BEHAVIORAL Cognitive Remediation Therapy
  • BEHAVIORAL Exposure Therapy for AN (AN-EX/RP)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-11
Est. Completion 2014-10
Phase NA

What the finished NCT01174602 record still lists

NCT01174602 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Cognitive Remediation Therapy is the first listed.

NCT01174602 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01174602 about?

NCT01174602 is a clinical study titled "Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa". Exposure and response prevention (AN-EXRP) will help individuals with anorexia nervosa improve their eating behavior.

What is the current status of trial NCT01174602?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-11. Estimated completion is 2014-10.

What interventions are being tested in trial NCT01174602?

The interventions under investigation include: Cognitive Remediation Therapy (BEHAVIORAL), Exposure Therapy for AN (AN-EX/RP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01174602?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01174602's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01174602, the US trial registry maintained by the National Library of Medicine. NCT01174602 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.